Footnotes

• Contributors BW assessed the patient during his inpatient admission and treated him for his opioid toxicity. BW suggested submitting the article for publication. BW wrote the case presentation and some of the discussion. BW coordinated the drafts and submitted the article. DE was the on-call pharmacist who provided advice for Naloxone therapy during the patient’s admission. He found that interaction was not commonly known about. DE wrote some of the discussion. DE wrote to the patient to get consent. MM saw the patient on his post take ward round. MM suggested BMJ case report as the journal to apply to. He also gave advice on consent and proof read the final draft. CS has been invited to review the paper following feedback from the reviewers. CS has experience with preparing manuscripts for submission. He has kindly reviewed the paper and improved the language and style of language.

• Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

• Competing interests None declared.

• Provenance and peer review Not commissioned; externally peer reviewed.

• Supplemental material This content has been supplied by the author(s). It has not been vetted by BMJ Publishing Group Limited (BMJ) and may not have been peer-reviewed. Any opinions or recommendations discussed are solely those of the author(s) and are not endorsed by BMJ. BMJ disclaims all liability and responsibility arising from any reliance placed on the content. Where the content includes any translated material, BMJ does not warrant the accuracy and reliability of the translations (including but not limited to local regulations, clinical guidelines, terminology, drug names and drug dosages), and is not responsible for any error and/or omissions arising from translation and adaptation or otherwise.